Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Koji Kurose
Observed names:
K. Kurose,
KOJI KUROSE,
KUROSE, Koji,
Kurose, Koji
Institution:
Kawasaki Medical School
Observed institutions:
Tokyo Medical University,
Okayama University,
Kawasaki Medical School,
Hiroshima University Hospital,
Nagasaki University,
Japanese Red Cross Nagasaki Genbaku Hospital,
Kawasaki University of Medical Welfare,
The University of Tokyo
show all 8
ORCID:
0000-0002-3878-1477
Observed ORCID:
0000-0002-3878-1477
OpenAlex ID:
A5035133419
Works
86
Awards
4
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients
2015
·
Koji Kurose
, Yoshihiro Ohue
, et al.
·
Clinical Cancer Research
·
244
Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760)
2014
·
Koji Kurose
, Yoshihiro Ohue
, et al.
·
Journal of Thoracic Oncology
·
59
PDF
Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells
2016
·
Yoshihiro Ohue
, Koji Kurose
, et al.
·
Cancer Immunology Research
·
53
Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti–Programmed Cell Death-1 Therapy in NSCLC
2019
·
Yoshihiro Ohue
, Koji Kurose
, et al.
·
Journal of Thoracic Oncology
·
47
PDF
Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors
2023
·
Kaoru Fujikawa
, Takuro Saito
, et al.
·
PLoS ONE
·
23
PDF
Prolongation of Overall Survival in Advanced Lung Adenocarcinoma Patients with the XAGE1 (GAGED2a) Antibody
2014
·
Yoshihiro Ohue
, Koji Kurose
, et al.
·
Clinical Cancer Research
·
22
Outbreak of Pertussis in a University Laboratory
2011
·
Naoyuki Miyashita
, Yasuhiro Kawai
, et al.
·
Internal Medicine
·
20
PDF
Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors
2025
·
Koichi Jinushi
, Takuro Saito
, et al.
·
Journal for ImmunoTherapy of Cancer
·
19
Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumors.
2021
·
Takuro Saito
, Koji Kurose
, et al.
·
PubMed
·
19
NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC
2017
·
Tomohira Takeoka
, Hirotsugu Nagase
, et al.
·
Journal of Immunotherapy
·
18
Thoracoscopic Findings in IgG4-related Pleuritis
2019
·
Naoya Yasokawa
, Ryo Shirai
, et al.
·
Internal Medicine
·
15
PDF
A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancer
2021
·
Yumiko Sakai
, Koji Kurose
, et al.
·
Clinica Chimica Acta
·
14
PDF
Step-down of budesonide/formoterol in early stages of asthma treatment leads to insufficient anti-inflammatory effect
2013
·
Yasushi Obase
, Masaki Ikeda
, et al.
·
Journal of Asthma
·
14
Abstract 4732: Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb.
2013
·
Koji Kurose
, Shingo Eikawa
, et al.
·
Cancer Research
·
11
Analysis of the relationship between comorbid obstructive sleep apnea and clinical outcomes in patients with asthma in Japan
2024
·
Hitomi Ikegami-Tanaka
, Naoya Yasokawa
, et al.
·
Allergology International
·
10
Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
2021
·
YUJI NOJIMA
, KATSUHIKO SHIMIZU
, et al.
·
Anticancer Research
·
8
Mechanical insufflation-exsufflation-related bilateral pneumothorax
2020
·
Naoya Yasokawa
, Hitomi Tanaka
, et al.
·
Respiratory Medicine Case Reports
·
8
PDF
Nivolumab-induced polyarthritis
2017
·
Shoko Kodama
, Koji Kurose
, et al.
·
BMJ Case Reports
·
8
PDF
Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis assay
2022
·
Shuichiro Okamoto
, Kei Miyano
, et al.
·
Biomedicine & Pharmacotherapy
·
7
HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC
2025
·
Kunihiko Funaishi
, Kakuhiro Yamaguchi
, et al.
·
Cancer Chemotherapy and Pharmacology
·
5
PDF
Predictive value of serum high‐mobility group box 1 levels for checkpoint inhibitor pneumonitis
2022
·
Hiroki Tanahashi
, Kakuhiro Yamaguchi
, et al.
·
Respirology
·
5
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
2022
·
Koji Kurose
, Kanako Sakaeda
, et al.
·
Advances in clinical chemistry
·
5
PDF
TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD)
2013
·
Yu Mizote
, Kazumasa Wakamatsu
, et al.
·
Journal of Dermatological Science
·
5
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer
2024
·
Kanako Sakaeda
, Koji Kurose
, et al.
·
Cancer Treatment and Research Communications
·
4
Generalized herpes zoster and cutaneous metastasis during chemotherapy for non‐small cell lung cancer: A case report
2020
·
Naoya Yasokawa
, Yuri Yasuda
, et al.
·
Thoracic Cancer
·
4
PDF
Show more works
View as search
Works count:
86
Citation count:
699
H-index:
13
I10-index:
16
Year
Topic
Type